Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | TSHR | P16473 | 4/20 | 1.00 |
| ▸ | CES2 | O00748 | 1/20 | 0.72 |
| ▸ | CES1 | P23141 | 1/20 | 0.72 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.59 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.59 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL206387 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRCES2CES1TP53 | |
| SCHEMBL10868553 | 0.96 | ALDH1A1 (0.93) | ALDH1A1TSHRCES2CES1TP53 | |
| SCHEMBL8590575 | 0.95 | ALDH1A1 (0.90) | ALDH1A1TSHRCES2CES1TP53 | |
| Benzoyl Chloride SCHEMBL11355880 | 0.95 | ALDH1A1 (0.90) | ALDH1A1TSHRCES2CES1TP53 | |
| SCHEMBL6260279 | 0.87 | ALDH1A1 (0.77) | ALDH1A1TSHRCES2CES1TP53 | |
| SCHEMBL8107324 | 0.86 | ALDH1A1 (0.74) | ALDH1A1TSHRCES2CES1TP53 | |
| SCHEMBL2106897 | 0.85 | KMT2A (0.76) | ALDH1A1TSHRKMT2AMEN1MAPT | |
| SCHEMBL181572 | 0.84 | CES2 (0.78) | ALDH1A1TSHRCES2CES1TP53 | |
| SCHEMBL2156825 | 0.84 | CES1 (1.00) | ALDH1A1TSHRCES2CES1TP53 | |
| SCHEMBL31374765 | 0.84 | CES1 (1.00) | ALDH1A1TSHRCES2CES1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4587030-A2 | NOVEL GLUCOCORTICOID RECEPTOR AGONISTS AND IMMUNOCONJUGATES THEREOF | Adcentrx Therapeutics Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20240383844-A1 | META-ESTER AROMATIC DIAMINES, METHOD FOR PRODUCING SAME, AND POLYIMIDE HAVING SAID META-ESTER AROMATIC DIAMINES AS RAW MATERIAL | SEIKA CORPORATION (JP) | 2024-11-21 | — | — | US | disclosed |
| US-20240239741-A1 | META-ESTER AROMATIC DIAMINES, METHOD FOR PRODUCING SAME, AND POLYIMIDE HAVING SAID META-ESTER AROMATIC DIAMINES AS RAW MATERIAL | SEIKA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| WO-2024059237-A2 | NOVEL GLUCOCORTICOID RECEPTOR AGONISTS AND IMMUNOCONJUGATES THEREOF | ADCENTRX THERAPEUTICS INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| CN-117295709-A | Meta-type ester aromatic diamine, process for producing the same, and polyimide using the meta-type ester aromatic diamine as raw material | 精化株式会社 | 2023-12-26 | — | — | CN | disclosed |
| WO-2023163227-A1 | ANTIBODY-DRUG CONJUGATE | ＵＢＥ株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023163234-A1 | ANTIBODY-DRUG CONJUGATE PRECURSOR AND INTERMEDIATE FOR SYNTHESIS THEREOF | ＵＢＥ株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2022239534-A1 | META-ESTER AROMATIC DIAMINES, METHOD FOR PRODUCING SAME, AND POLYIMIDE HAVING SAID META-ESTER AROMATIC DIAMINES AS RAW MATERIAL | セイカ株式会社 | 2022-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239741-A1 | META-ESTER AROMATIC DIAMINES, METHOD FOR PRODUCING SAME, AND POLYIMIDE HAVING SAID META-ESTER AROMATIC DIAMINES AS RAW MATERIAL | PRMT9, DDC, AOC1 | ALDH1A1 931/4885TSHR 2464/4885CES2 1403/4885 |
| US-20240383844-A1 | META-ESTER AROMATIC DIAMINES, METHOD FOR PRODUCING SAME, AND POLYIMIDE HAVING SAID META-ESTER AROMATIC DIAMINES AS RAW MATERIAL | PRMT9, DDC, AOC1 | ALDH1A1 931/4885TSHR 2464/4885CES2 1403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.